Patents by Inventor Jonathon Patrick Roepke

Jonathon Patrick Roepke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260137828
    Abstract: Provided are peptides that are derived from probiotic bacteria that may be useful for preventing and/or treating enteric infections or non-enteric infections in a subject. The peptides may also find use for reducing the virulence of enteric infections or non-enteric infections in a subject. Also provided are compositions of the peptides and compositions comprising culture fractions of the probiotic bacteria.
    Type: Application
    Filed: November 26, 2025
    Publication date: May 21, 2026
    Inventors: Monica Angela Cella, Sarah M. Curtis, Jonathon Patrick Roepke
  • Publication number: 20250313595
    Abstract: Provided are peptides that are derived from probiotic bacteria that have use for preventing and/or treating non-enteric infections in a subject. The peptides derived from the probiotic bacteria also have use for reducing the virulence of non-enteric infections in a subject. Also provided are compositions of the peptides formulated as or within food products, beverages, nutritional supplements, medicaments and the like.
    Type: Application
    Filed: June 18, 2025
    Publication date: October 9, 2025
    Inventors: Monica Angela Cella, Sarah M. Curtis, Jonathon Patrick Roepke
  • Publication number: 20240150399
    Abstract: Provided are peptides that are derived from probiotic bacteria that have use for preventing and/or treating non-enteric infections in a subject. The peptides derived from the probiotic bacteria also have use for reducing the virulence of non-enteric infections in a subject. Also provided are compositions of the peptides formulated as or within food products, beverages, nutritional supplements, medicaments and the like.
    Type: Application
    Filed: January 15, 2024
    Publication date: May 9, 2024
    Inventors: Monica Angela Cella, Sarah M. Curtis, Jonathon Patrick Roepke
  • Patent number: 11912788
    Abstract: Provided are peptides that are derived from probiotic bacteria that have use for preventing and/or treating non-enteric infections in a subject. The peptides derived from the probiotic bacteria also have use for reducing the virulence of non-enteric infections in a subject. Also provided are compositions of the peptides formulated as or within food products, beverages, nutritional supplements, medicaments and the like.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: February 27, 2024
    Assignee: MICROSINTESIS INC.
    Inventors: Monica Angela Cella, Sarah M. Curtis, Jonathon Patrick Roepke
  • Publication number: 20240016970
    Abstract: Provided are peptides that are derived from probiotic bacteria that may be useful for preventing and/or treating enteric infections or non-enteric infections in a subject. The peptides may also find use for reducing the virulence of enteric infections or non-enteric infections in a subject. Also provided are compositions of the peptides and compositions comprising culture fractions of the probiotic bacteria.
    Type: Application
    Filed: June 2, 2023
    Publication date: January 18, 2024
    Inventors: Monica Angela Cella, Sarah M. Curtis, Jonathon Patrick Roepke
  • Publication number: 20200017547
    Abstract: Provided are peptides that are derived from probiotic bacteria that have use for preventing and/or treating non-enteric infections in a subject. The peptides derived from the probiotic bacteria also have use for reducing the virulence of non-enteric infections in a subject. Also provided are compositions of the peptides formulated as or within food products, beverages, nutritional supplements, medicaments and the like.
    Type: Application
    Filed: March 16, 2018
    Publication date: January 16, 2020
    Inventors: Monica Angela Cella, Sarah M. Curtis, Jonathon Patrick Roepke
  • Publication number: 20200016290
    Abstract: Provided are peptides that are derived from probiotic bacteria that may be useful for preventing and/or treating enteric infections or non-enteric infections in a subject. The peptides may also find use for reducing the virulence of enteric infections or non-enteric infections in a subject. Also provided are compositions of the peptides and compositions comprising culture fractions of the probiotic bacteria.
    Type: Application
    Filed: March 16, 2018
    Publication date: January 16, 2020
    Inventors: Monica Angela Cella, Sarah M. Curtis, Jonathon Patrick Roepke